86
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women

, , , , , & show all
Pages 479-484 | Published online: 25 Jun 2014

References

  • SkałbaPGuzMHypogonadotropic hypogonadism in womenEndokrynol Pol201162656056722144224
  • Practice Committee of American Society for Reproductive MedicineUse of exogenous gonadotropins in anovulatory women: a technical bulletinFertil Steril200890Suppl 5S7S1219007651
  • SilveiraLFLatronicoALApproach to the patient with hypogonadotropic hypogonadismJ Clin Endocrinol Metab2013981781178823650335
  • CaroneDCaropresoCVittiAChiappettaREfficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocolsJ Endocrinol Invest20123511996100223095369
  • PopatVGonadotropin-releasing hormone deficiency in adultsThe European Journal of Endocrinology [online]JE Publishing2012 Available from: http://ej-endocrinology.org/gnrh.htmlAccessed September 13, 2013
  • HuirneJALambalkCBvan LoenenACContemporary pharmacological manipulation in assisted reproductionDrugs20046429732214871171
  • SmithMGOn the interruption of pregnancy in the rat by the injection of ovarian follicular extractBull Johns Hopkins Hosp192639420321412255683
  • FevoldHLHisawFLLeonardSLThe gonad-stimulating and the luteinizing hormones of the anterior lobe of the hypophysisAm J Physiol193197291301 Available from: http://ajplegacy.physiology.org/content/ajplegacy/97/2/291.full.pdfAccessed May 22, 2014
  • LunenfeldBHistorical perspectives in gonadotrophin therapyHum Reprod Update200410645346715388674
  • LoumayeECampbellRSalat-BarouxJHuman follicle-stimulating hormone produced by recombinant DNA technology: a review for cliniciansHum Reprod Update19951218819915726772
  • HullMCorriganEPiazziALoumayeERecombinant human luteinising hormone: an effective new gonadotropin preparationLancet19943443343357914279
  • [No authors listed]Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study GroupJ Clin Endocrinol Metab1998835150715149589647
  • RowePJCombaireFHHargreaveTBWHO manual for the standardized investigation and diagnosis of the infertile coupleCambridge University Press2001
  • BühlerKNaetherOA 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational studyGynecol Endocrinol201127965065420849209
  • BühlerKFFischerRRecombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control studyGynecol Endocrinol201228534535022115012
  • Codifa [database on the Internet]MilanEDRA LSWR SpA Available from: http://www.codifa.itAccessed July 25, 2013 Italian
  • HuguesJNSoussisJCalderonIBalaschJAndersonRARomeuARecombinant LH Study GroupDoes the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding studyHum Reprod200520362963515618252
  • BurguésSSpanish Collaborative Group on Female Hypogonadotrophic HypogonadismThe effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in SpainHum Reprod200116122525253211726569
  • KaufmannRDunnRVaughnTRecombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient womenClin Endocrinol (Oxf)200767456356917692110
  • BoschERecombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applicationsExpert Opin Biol Ther20101061001100920415593
  • RevelliAPosoFGennarelliGMoffaFGrassiGMassobrioMRecombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysisReprod Biol Endocrinol200643816848893
  • MencacciCAgugliaEBiggioGC-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in ItalyAdv Ther201330769771223929174
  • ColomboGLDi MatteoSMaggioloFAntiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimenClinicoecon Outcomes Res20135596823430273